HANNAH PITTMAN: Open Payments
NPI 1609647494 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $231 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Innovation Technologies Inc | 2 | $56 |
| Teleflex LLC | 3 | $54 |
| Antares Pharma, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Endo USA, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: RYBREVANT, ERLEADA, GEMTESA, IRRISEPT, BARRIGEL, XYOSTED, JOURNAVX, UROLIFT.
Industry payments across MS — which companies pay providers there.
